{
  "case_id": "Case_4",
  "model_id": "openai/gpt-4o",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Glycogen storage disease type V (McArdle disease)\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"E74.0\",\n        \"reasoning\": \"The symptoms of exercise intolerance, muscle weakness, episodes of dark urine, and elevated CK levels after intense physical activity are characteristic of McArdle disease, especially given the consanguineous parents suggesting a genetic disorder.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Carnitine palmitoyltransferase II deficiency\",\n            \"confidence\": 0.7,\n            \"icd_code\": \"E71.3\",\n            \"reasoning\": \"This condition also presents with exercise intolerance, muscle pain, and myoglobinuria, particularly after prolonged exercise.\"\n        },\n        {\n            \"name\": \"Duchenne muscular dystrophy\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"G71.0\",\n            \"reasoning\": \"Though less likely due to episodic nature, muscle weakness and elevated CK levels can be seen, but typically presents earlier in childhood.\"\n        },\n        {\n            \"name\": \"Myoadenylate deaminase deficiency\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"E79.8\",\n            \"reasoning\": \"Presents similarly with muscle cramps after exercise, but less common and typically does not cause dark urine.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Exercise intolerance\",\n        \"Episodes of dark urine after exercise\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Genetic testing for PYGM gene mutations\",\n            \"purpose\": \"To confirm McArdle disease\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Muscle biopsy\",\n            \"purpose\": \"To assess glycogen accumulation\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Acylcarnitine profile\",\n            \"purpose\": \"To rule out carnitine palmitoyltransferase II deficiency\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Educate on avoiding strenuous exercise\",\n            \"Hydration to prevent myoglobinuria\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Sucrose\",\n                \"dose\": \"10-20g\",\n                \"route\": \"PO\",\n                \"duration\": \"Before exercise\",\n                \"rationale\": \"To prevent muscle breakdown during activity\"\n            }\n        ],\n        \"monitoring\": [\n            \"CK levels\",\n            \"Monthly during initial management\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Genetics\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For genetic counseling due to consanguineous parents\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Severe muscle pain and swelling\",\n        \"Dark urine persisting beyond 24 hours\"\n    ],\n    \"patient_education\": [\n        \"Importance of avoiding strenuous exercise\",\n        \"Recognition of dark urine as a sign of muscle breakdown\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 month\",\n        \"conditions\": \"Worsening muscle weakness or persistent dark urine\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Exact genetic mutation confirmation\",\n        \"Long-term management plan adjustments\"\n    ]\n}\n```",
  "latency": 7.745887041091919,
  "timestamp": "2025-08-10T01:11:08.481728",
  "cached_at": "2025-08-10T01:11:08.481734"
}